Drug Profile
VB 100
Alternative Names: VB-100; VITA-100Latest Information Update: 30 Dec 2021
Price :
$50
*
At a glance
- Originator Vitality Biopharma
- Developer Malachite Innovations
- Class Anti-inflammatories; Cannabinoids
- Mechanism of Action Cannabinoid receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Inflammatory bowel diseases
Most Recent Events
- 28 Sep 2020 No recent reports of development identified for preclinical development in Inflammatory-bowel-diseases in USA (PO)
- 03 Aug 2016 Vitality Biopharma has patents covering Cannabinoid prodrugs (Corporate presentation, July 2016)
- 03 Aug 2016 Preclinical trials in Inflammatory bowel disease in USA (PO) prior to August 2016